Lovejoy Travis I, Dobscha Steven K, Turk Dennis C, Weimer Melissa B, Morasco Benjamin J
Mental Health and Clinical Neurosciences Division and Center to Improve Veteran Involvement in Care, Department of Veterans Affairs Portland Health Care System, Portland, OR; and Department of Psychiatry, Oregon Health and Science University, Portland, OR;
J Rehabil Res Dev. 2016;53(1):25-36. doi: 10.1682/JRRD.2014.10.0230.
Patients with a history of substance use disorder (SUD) are more likely to be prescribed opioid medications for chronic pain than patients without an SUD history; however, little is known about prescription opioid therapy in populations composed exclusively of patients with SUD. This study examined correlates of prescription opioid therapy in 214 Veterans with chronic noncancer pain and an SUD history. Participants completed psychosocial questionnaires and participated in a structured mental health diagnostic interview, and medical diagnoses and opioid pharmacy data were abstracted from their Department of Veterans Affairs electronic medical records. Participants were categorized into three groups based on opioid prescriptions in the past 90 d: no opioid therapy (n = 134), short-term (<90 d) opioid therapy (n = 31), or long-term (>/= 90 d) opioid therapy (n = 49). Relative to participants prescribed no or short-term opioid therapy, participants who were prescribed long-term opioid therapy had a greater number of pain diagnoses; reported higher levels of pain severity, interference, and catastrophizing; and endorsed lower chronic pain self-efficacy. In a multivariate model, number of pain diagnoses and pain interference were associated with a greater likelihood of being prescribed long-term opioid therapy after controlling for demographic and clinical characteristics. Findings highlight the poor pain-related functioning in patients with SUD histories who are prescribed long-term opioid therapy.
有物质使用障碍(SUD)病史的患者比没有SUD病史的患者更有可能因慢性疼痛而被开具阿片类药物;然而,对于仅由患有SUD的患者组成的人群中的处方阿片类药物治疗知之甚少。本研究调查了214名患有慢性非癌性疼痛且有SUD病史的退伍军人中处方阿片类药物治疗的相关因素。参与者完成了心理社会调查问卷并参加了结构化的心理健康诊断访谈,医疗诊断和阿片类药物药房数据从他们的退伍军人事务部电子病历中提取。根据过去90天内的阿片类药物处方,参与者被分为三组:无阿片类药物治疗(n = 134)、短期(<90天)阿片类药物治疗(n = 31)或长期(≥90天)阿片类药物治疗(n = 49)。与未接受或接受短期阿片类药物治疗的参与者相比,接受长期阿片类药物治疗的参与者有更多的疼痛诊断;报告的疼痛严重程度、干扰和灾难化水平更高;并且认可较低的慢性疼痛自我效能感。在多变量模型中,在控制了人口统计学和临床特征后,疼痛诊断数量和疼痛干扰与接受长期阿片类药物治疗的可能性更大相关。研究结果突出了接受长期阿片类药物治疗的有SUD病史患者在疼痛相关功能方面的不佳表现。